Cisplatin, methotrexate and vinblastine plus surgical restaging for patients with advanced transitional cell carcinoma of the urothelium

Journal of Urology

Volumn 150, Issue 1, 1993, Pages 65-69

  Miller, R S ^a   Freiha, F S ^a   Reese, J H ^a   Ozen, H ^a   Torti, F M ^a  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

bladder neoplasms; carcinoma, transitional cell; cisplatin; methotrexate; vinblastine

Indexed keywords

CISPLATIN; METHOTREXATE; VINBLASTINE;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER STAGING; CANCER SURVIVAL; CYSTECTOMY; DRUG RESPONSE; FEMALE; FEVER; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NAUSEA; NEPHROTOXICITY; NEPHROURETERECTOMY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; URINARY TRACT CARCINOMA; VOMITING;

EID: 0027214852     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(17)35398-3     Document Type: Article

References (15)

1. W.F. Whitmore Jr. Management of invasive bladder neoplasms Sem. Urol. 1 1983 34
2. J.A. Smith Jr. W.F. Whitmore Jr. Regional lymph node metastasis from bladder cancer J. Urol 126 1981 591
3. D. Raghavan W.U. Shipley M.B. Garnick P.J. Russell J.P. Richie Biology and management of bladder cancer New Engl. J. Med. 322 1990 1129
4. D. Raghavan B. Pearson W.H. Watt H. Mameghan P. Langdon D. Eisinger R. Wines Cytotoxic chemotherapy for advanced bladder cancer: cisplatin-containing regimens Sem. Oncol. 18 suppl 3 1991 56
5. W.G. Harker F.J. Meyers F.S. Freiha J.M. Palmer L.D. Shortliffe J.F. Hannigan K.M. McWhirter F.M. Torti Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study J. Clin. Oncol. 3 1985 1463
6. E.L. Kaplan P. Meier Nonparametric estimation from incomplete observations J. Amer. Stat. Ass. 53 1958 457
7. C. Boring T. Squires T. Tong Cancer Statistics, 1992 CA 42 1992 19
8. H.W. Herr Cis-diamminedichloride platinum II in the treatment of advanced bladder cancer J. Urol. 123 1980 853
9. R. Oliver E.S. Newlands Wiltshaw J.S. Malpas A phase 2 study of cis-platinum in patients with recurrent bladder carcinoma. The London and Oxford Co-Operative Urological Cancer Group Brit. J. Urol. 53 1981 444
10. P.C. Peters M.R. O’Neill Cis-diamminedichloroplatinum as a therapeutic agent in metastatic transitional cell carcinoma J. Urol. 123 1980 375
11. A. Yagoda Phase II trials with cis-dichlorodiammineplatinum (II) in the treatment of urothelial cancer Cancer Treat. Rep. 63 1979 1565
12. B.L. Hillcoat D. Raghavan J. Matthews R. Kefford K. Yuen R. Woods I. Olver J. Bishop B. Pearson G. Coorey A randomized trial of cisplatin versus cisplatin plus methotrexate in advanced cancer of the urothelial tract J. Clin. Oncol. 7 1989 706
13. M. Troner R. Birch G.A. Omura S. Williams Phase III comparison of cisplatin alone versus cisplatin, doxorubicin and cyclophosphamide in the treatment of bladder (urothelial) cancer: a Southeastern Cancer Study Group trial J. Urol. 137 1987 660
14. P.J. Loehrer Sr. L.H. Einhorn P.J. Elson E.D. Crawford P. Kuebler I. Tannock D. Raghavan R. Stuart-Harris M.F. Sarosdy B.A. Lowe B. Blumenstein D. Trump A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study J. Clin. Oncol. 10 1992 1066
15. C.J. Logothetis F.H. Dexeus L. Finn A. Sella R.J. Amato A.G. Ayala R.G. Kilbourn A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors J. Clin. Oncol. 8 1990 1050